Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
Pancreatic cancer is a dismal disorder that is histologically characterized by a dense fibrotic stroma around the tumor cells. As the extracellular matrix comprises the bulk of the stroma, matrix degrading proteases may play an important role in pancreatic cancer. It has been suggested that matrix m...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-04-01
|
| Series: | Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-7737/9/4/80 |
| _version_ | 1797570253936394240 |
|---|---|
| author | Etienne J. Slapak JanWillem Duitman Cansu Tekin Maarten F. Bijlsma C. Arnold Spek |
| author_facet | Etienne J. Slapak JanWillem Duitman Cansu Tekin Maarten F. Bijlsma C. Arnold Spek |
| author_sort | Etienne J. Slapak |
| collection | DOAJ |
| description | Pancreatic cancer is a dismal disorder that is histologically characterized by a dense fibrotic stroma around the tumor cells. As the extracellular matrix comprises the bulk of the stroma, matrix degrading proteases may play an important role in pancreatic cancer. It has been suggested that matrix metalloproteases are key drivers of both tumor growth and metastasis during pancreatic cancer progression. Based upon this notion, changes in matrix metalloprotease expression levels are often considered surrogate markers for pancreatic cancer progression and/or treatment response. Indeed, reduced matrix metalloprotease levels upon treatment (either pharmacological or due to genetic ablation) are considered as proof of the anti-tumorigenic potential of the mediator under study. In the current review, we aim to establish whether matrix metalloproteases indeed drive pancreatic cancer progression and whether decreased matrix metalloprotease levels in experimental settings are therefore indicative of treatment response. After a systematic review of the studies focusing on matrix metalloproteases in pancreatic cancer, we conclude that the available literature is not as convincing as expected and that, although individual matrix metalloproteases may contribute to pancreatic cancer growth and metastasis, this does not support the generalized notion that matrix metalloproteases drive pancreatic ductal adenocarcinoma progression. |
| first_indexed | 2024-03-10T20:23:18Z |
| format | Article |
| id | doaj.art-854e41da336842e683ff4162e4fd55ac |
| institution | Directory Open Access Journal |
| issn | 2079-7737 |
| language | English |
| last_indexed | 2024-03-10T20:23:18Z |
| publishDate | 2020-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biology |
| spelling | doaj.art-854e41da336842e683ff4162e4fd55ac2023-11-19T22:01:23ZengMDPI AGBiology2079-77372020-04-01948010.3390/biology9040080Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?Etienne J. Slapak0JanWillem Duitman1Cansu Tekin2Maarten F. Bijlsma3C. Arnold Spek4Center of Experimental and Molecular Medicine, University of Amsterdam, Amsterdam UMC, 1105 AZ Amsterdam, The NetherlandsCenter of Experimental and Molecular Medicine, University of Amsterdam, Amsterdam UMC, 1105 AZ Amsterdam, The NetherlandsCenter of Experimental and Molecular Medicine, University of Amsterdam, Amsterdam UMC, 1105 AZ Amsterdam, The NetherlandsLaboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, University of Amsterdam, Amsterdam UMC, 1105 AZ Amsterdam, The NetherlandsCenter of Experimental and Molecular Medicine, University of Amsterdam, Amsterdam UMC, 1105 AZ Amsterdam, The NetherlandsPancreatic cancer is a dismal disorder that is histologically characterized by a dense fibrotic stroma around the tumor cells. As the extracellular matrix comprises the bulk of the stroma, matrix degrading proteases may play an important role in pancreatic cancer. It has been suggested that matrix metalloproteases are key drivers of both tumor growth and metastasis during pancreatic cancer progression. Based upon this notion, changes in matrix metalloprotease expression levels are often considered surrogate markers for pancreatic cancer progression and/or treatment response. Indeed, reduced matrix metalloprotease levels upon treatment (either pharmacological or due to genetic ablation) are considered as proof of the anti-tumorigenic potential of the mediator under study. In the current review, we aim to establish whether matrix metalloproteases indeed drive pancreatic cancer progression and whether decreased matrix metalloprotease levels in experimental settings are therefore indicative of treatment response. After a systematic review of the studies focusing on matrix metalloproteases in pancreatic cancer, we conclude that the available literature is not as convincing as expected and that, although individual matrix metalloproteases may contribute to pancreatic cancer growth and metastasis, this does not support the generalized notion that matrix metalloproteases drive pancreatic ductal adenocarcinoma progression.https://www.mdpi.com/2079-7737/9/4/80MMPMMP2MMP9MMP7MMP14matrix metalloproteases |
| spellingShingle | Etienne J. Slapak JanWillem Duitman Cansu Tekin Maarten F. Bijlsma C. Arnold Spek Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? Biology MMP MMP2 MMP9 MMP7 MMP14 matrix metalloproteases |
| title | Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? |
| title_full | Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? |
| title_fullStr | Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? |
| title_full_unstemmed | Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? |
| title_short | Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? |
| title_sort | matrix metalloproteases in pancreatic ductal adenocarcinoma key drivers of disease progression |
| topic | MMP MMP2 MMP9 MMP7 MMP14 matrix metalloproteases |
| url | https://www.mdpi.com/2079-7737/9/4/80 |
| work_keys_str_mv | AT etiennejslapak matrixmetalloproteasesinpancreaticductaladenocarcinomakeydriversofdiseaseprogression AT janwillemduitman matrixmetalloproteasesinpancreaticductaladenocarcinomakeydriversofdiseaseprogression AT cansutekin matrixmetalloproteasesinpancreaticductaladenocarcinomakeydriversofdiseaseprogression AT maartenfbijlsma matrixmetalloproteasesinpancreaticductaladenocarcinomakeydriversofdiseaseprogression AT carnoldspek matrixmetalloproteasesinpancreaticductaladenocarcinomakeydriversofdiseaseprogression |